Gene · 2118
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epithelial YAP1 Regulates Ameloblast Differentiation through SHH/FGF Signaling. | J Dent Res | 2025 | 40444759 | PubTator, text mining | PubMed |
| ETV4 promotes the growth, metastasis, glycolysis, and oxaliplatin resistance of colorectal cancer by transcription activation-mediated SLC38A5 upregulation. | Pathol Res Pract | 2025 | 40435908 | PubTator, text mining | PubMed |
| ETS emerges to heat up adipose. | Genes Dev | 2025 | 40389324 | PubTator, text mining | PubMed |
| Molecular heterogeneity of small cell lung cancer and new therapeutic possibilities: a narrative review of the literature. | Transl Lung Cancer Res | 2025 | 40386726 | PubTator, text mining | PubMed |
| Development and validation of tryptophan metabolism-related risk model and molecular subtypes for predicting postoperative biochemical recurrence in prostate cancer. | Transl Androl Urol | 2025 | 40376539 | PubTator, text mining | PubMed |
| The Extensive Case Series of 21 CIC::DUX4 , 18 BCOR::CCNB3 and 148 Ewing's Sarcomas From a Single Center. | Am J Surg Pathol | 2025 | 40298239 | PubTator, text mining | PubMed |
| PEA3 Transcription Factors, Role in Invasion, Proliferation and Radioresistance of Glioblastoma Stem Cells. | J Cell Mol Med | 2025 | 40275610 | PubTator, text mining | PubMed |
| ETV4/ALYREF-mediated glycolytic metabolism through PKM2 enhances resistance to ferroptosis and promotes the development of intrahepatic cholangiocarcinoma. | Cancer Metab | 2025 | 40264211 | PubTator, text mining | PubMed |
| Development of p300-targeting degraders with enhanced selectivity and onset of degradation. | RSC Med Chem | 2025 | 40093518 | PubTator, text mining | PubMed |
| Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers. | Mol Cancer | 2025 | 40087745 | PubTator, text mining | PubMed |
| Single-nuclei sequencing of skeletal muscle reveals subsynaptic-specific transcripts involved in neuromuscular junction maintenance. | Nat Commun | 2025 | 40044687 | PubTator, text mining | PubMed |
| Identification of ETV4 as a prognostic biomarker and correlates with immune cell infiltration in head and neck squamous cell carcinoma. | Sci Rep | 2025 | 40016264 | PubTator, text mining | PubMed |
| ETVs dictate hPSC differentiation by tuning biophysical properties. | Nat Commun | 2025 | 40011454 | PubTator, text mining | PubMed |
| Sinonasal EWSR1::POU2AF3 sarcoma: a case report and literature review. | Virchows Arch | 2025 | 39982522 | PubTator, text mining | PubMed |
| Impairment of DET1 causes neurological defects and lethality in mice and humans. | Proc Natl Acad Sci U S A | 2025 | 39937864 | PubTator, text mining | PubMed |
| Ancillary Tools for the Diagnosis of CIC -Rearranged Sarcoma: A Comprehensive Review. | J Cutan Pathol | 2025 | 39921488 | PubTator, text mining | PubMed |
| Hyodeoxycholic acid ameliorates cholestatic liver fibrosis by facilitating m6A-regulated expression of a novel anti-fibrotic target ETV4. | J Hepatol | 2025 | 39914744 | PubTator, text mining | PubMed |
| A comprehensive multi-omics study reveals potential prognostic and diagnostic biomarkers for colorectal cancer. | Int J Biol Macromol | 2025 | 39909246 | PubTator, text mining | PubMed |
| Different expression of circulating microRNA profile in tibetan OSAHS with metabolic syndrome patients. | Sci Rep | 2025 | 39849122 | PubTator, text mining | PubMed |
| Sox17 and Erg synergistically activate endothelial cell fate in reprogramming fibroblasts. | J Mol Cell Cardiol | 2025 | 39689498 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2118/papers?page=5